WASHINGTON — The Trump administration has imposed a six-month moratorium on new Medicare enrollments for hospice and home health agencies, a move aimed at curbing widespread fraud in the program. Announced on Wednesday, the pause is part of a broader crackdown on providers suspected of exploiting the system, according to the Centers for Medicare & Medicaid Services (CMS).
The decision comes amid growing concerns over fraudulent activities in the hospice sector, where agencies have been accused of enrolling patients who do not qualify for end-of-life care to collect reimbursements. CMS, the federal agency overseeing Medicare, stated that the moratorium will allow for heightened scrutiny of existing and prospective providers. "CMS will intensify targeted investigations, deploy advanced data analytics, and accelerate the removal of hospice and HHA providers from the Medicare program that are suspected of committing fraud," the agency said in an official statement.
This action affects thousands of agencies nationwide, particularly in high-fraud areas like South Florida and Southern California, where investigations have uncovered schemes involving unnecessary enrollments and billing for services not rendered. The moratorium, effective immediately, halts the processing of new applications for Medicare billing privileges by these providers, giving regulators time to weed out bad actors without allowing new ones to enter the fold.
Officials with the Department of Health and Human Services (HHS), which houses CMS, emphasized that the pause is temporary but necessary to protect taxpayer dollars. Medicare, the federal health insurance program for people 65 and older and certain younger individuals with disabilities, spends billions annually on hospice care. In recent years, audits have revealed improper payments exceeding $1 billion in the hospice benefit alone, according to government reports.
The announcement follows a series of high-profile enforcement actions under the Trump administration, which has prioritized fighting healthcare fraud as part of its "Make America Healthy Again" initiative. Earlier this year, federal prosecutors in Miami indicted several hospice operators on charges of defrauding Medicare out of millions by certifying healthy patients as terminally ill. Those cases highlighted systemic vulnerabilities, including lax oversight and the rapid proliferation of for-profit hospice chains.
Industry representatives expressed mixed reactions to the news. The National Hospice and Palliative Care Organization (NHPCO), a leading trade group, acknowledged the need to address fraud but warned that the blanket moratorium could hinder legitimate providers from expanding services in underserved areas. "While we support efforts to eliminate bad actors, this measure may inadvertently impact access to care for vulnerable patients," said NHPCO President and CEO Edo Banach in a statement released Thursday.
On the other side, patient advocacy groups welcomed the step. AARP, the nation's largest nonprofit for seniors, praised the administration for taking decisive action. "Medicare fraud not only drains resources but also undermines trust in the program that millions rely on," said AARP Senior Vice President for Government Relations David Certner. He noted that hospice services, intended for those with six months or less to live, have seen enrollment surge by over 200 percent in the past decade, raising red flags about overutilization.
Background on the hospice industry's growth provides context for the administration's concerns. Since the 1980s, when Medicare first covered hospice benefits, the number of agencies has ballooned from a few hundred to more than 5,000 today. For-profit entities now dominate, comprising about 60 percent of providers, up from just 10 percent two decades ago. Critics argue this shift has incentivized aggressive marketing and enrollment practices, leading to what some call a "wild west" in end-of-life care.
The moratorium is not without precedent. In 2014, under the Obama administration, CMS implemented a similar pause in certain Florida counties after fraud rates soared. That effort resulted in the revocation of billing privileges for over 100 providers and recovered millions in fraudulent claims. Trump officials cited those outcomes as a model for the current nationwide approach, which expands the scope to all hospice and home health agencies (HHA).
Home health agencies, which provide in-home medical services, face similar scrutiny due to overlapping fraud patterns. Reports from the Department of Justice indicate that HHAs have been involved in schemes billing for phantom visits and kickback arrangements with physicians. The six-month window, CMS said, will enable the use of sophisticated tools like predictive modeling to identify suspicious patterns in billing data.
Legal experts predict the move could face challenges in court. "Providers who are compliant may argue that they're being unfairly penalized," said health law professor Timothy Jost of Washington and Lee University School of Law. He pointed to past lawsuits where moratoriums were deemed overly broad, though he added that courts have generally upheld CMS's authority to protect the program's integrity.
As the story develops, questions remain about the moratorium's implementation. CMS has not specified how it will handle pending applications or provide guidance on exceptions for rural or shortage areas. Officials promised more details in coming weeks, but for now, the agency is urging providers to review their compliance status proactively.
The broader implications extend to Medicare's sustainability. With the baby boomer generation aging, demand for hospice and home health services is projected to double by 2030, according to the Medicare Payment Advisory Commission. Fraudulent activity exacerbates the program's financial pressures, which already face shortfalls projected for the late 2020s. By targeting these sectors, the administration aims to safeguard funds for legitimate care.
Stakeholders on Capitol Hill have taken note. Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) commended the effort but called for bipartisan legislation to strengthen oversight permanently. Meanwhile, House Energy and Commerce Committee Chairman Greg Walden (R-Ore.) echoed support, stating in a tweet that "combating healthcare fraud is a priority we can all get behind."
Looking ahead, the moratorium could set the tone for future regulatory actions. If successful, it might expand to other Medicare providers prone to abuse, such as durable medical equipment suppliers. For patients and families navigating end-of-life decisions, the hope is that cleaner operations will ensure compassionate care without the shadow of exploitation. CMS officials indicated that updates on the initiative's progress will be shared as investigations unfold, marking this as an evolving chapter in the fight against healthcare fraud.